Publications

Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study

Assessing the reproducibility, accuracy and utility of massively parallel DNA sequencing platforms remains an ongoing challenge. Here the Association of Biomolecular Resource Facilities (ABRF) Next-Generation Sequencing Study benchmarks the performance of a set of sequencing instruments (HiSeq/NovaSeq/paired-end 2 × 250-bp chemistry, Ion S5/Proton, PacBio circular consensus sequencing (CCS), Oxford Nanopore Technologies PromethION/MinION, BGISEQ-500/MGISEQ-2000 and GS111) on human and bacterial reference DNA samples. Among short-read instruments, HiSeq 4000 and X10 provided the most consistent, highest genome coverage, while BGI/MGISEQ provided the lowest sequencing error rates. The long-read instrument PacBio CCS had the highest reference-based mapping rate and lowest non-mapping rate. The two long-read platforms PacBio CCS and PromethION/MinION showed the best sequence mapping in repeat-rich areas and across homopolymers. NovaSeq 6000 using 2 × 250-bp read chemistry was the most robust instrument for capturing known insertion/deletion events. This study serves as a benchmark for current genomics technologies, as well as a resource to inform experimental design and next-generation sequencing variant calling.
Nat Biotechnol. 2021 Sep;39(9):1129-1140. doi: 10.1038/s41587-021-01049-5.

Authors

Other Contributors

1Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.

2The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.

3University of Vermont Cancer Center, Vermont Integrative Genomics Resource, University of Vermont, Burlington, VT, USA.

4Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

5Biosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, MD, USA.

6New York Genome Center, New York, NY, USA.

7Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.

8Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

9Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, USA.

10DNA Sequencing Core, University of Utah, Salt Lake City, UT, USA.

11Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.

12Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

13HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.

14BGI-Shenzhen, Shenzhen, China.

15MGI, BGI-Shenzhen, Shenzhen, China.

16Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.

17Guangdong Provincial Key Laboratory of Genome Read and Write, Shenzhen, China.

18Illumina, Inc., San Diego, CA, USA.

19Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL, USA.

20Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.

21Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

22Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA.

23Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.

24The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.

25The Feil Family Brain and Mind Research Institute, New York, NY, USA.

26The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA.

loading...